A detailed history of Caption Management, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Caption Management, LLC holds 18,000 shares of BIIB stock, worth $2.68 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
18,000
Previous 18,000 -0.0%
Holding current value
$2.68 Million
Previous $4.17 Million 16.37%
% of portfolio
0.06%
Previous 0.07%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$189.07 - $236.8 $378,140 - $473,600
-2,000 Reduced 52.91%
1,780 $345,000
Q2 2024

Aug 14, 2024

BUY
$190.52 - $236.72 $720,165 - $894,801
3,780 New
3,780 $876,000
Q4 2022

Feb 14, 2023

BUY
$252.44 - $306.72 $3.03 Million - $3.68 Million
12,000 New
12,000 $3.32 Million
Q2 2022

Aug 15, 2022

BUY
$187.54 - $223.02 $683,770 - $813,130
3,646 Added 5.09%
75,346 $15.4 Million
Q1 2022

May 13, 2022

SELL
$193.77 - $244.14 $31.6 Million - $39.9 Million
-163,300 Reduced 69.49%
71,700 $15.1 Million
Q4 2021

Feb 11, 2022

BUY
$223.92 - $287.77 $2.62 Million - $3.37 Million
11,700 Added 5.24%
235,000 $56.4 Million
Q3 2021

Nov 12, 2021

BUY
$282.99 - $369.05 $15.3 Million - $19.9 Million
53,996 Added 31.89%
223,300 $63.2 Million
Q2 2021

Aug 16, 2021

BUY
$259.0 - $414.71 $24.3 Million - $38.9 Million
93,830 Added 124.32%
169,304 $58.6 Million
Q1 2021

May 17, 2021

BUY
$242.95 - $284.63 $15.2 Million - $17.8 Million
62,674 Added 489.64%
75,474 $21.1 Million
Q3 2020

Nov 16, 2020

BUY
$264.77 - $305.71 $3.39 Million - $3.91 Million
12,800 New
12,800 $3.63 Million
Q1 2020

May 15, 2020

SELL
$268.85 - $341.04 $1.49 Million - $1.89 Million
-5,540 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$220.06 - $304.07 $1.22 Million - $1.68 Million
5,540 New
5,540 $1.64 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.